Genetic mutations are important in the healthcare setting because they can influence a person's susceptibility to disease and treatment response. In genomics, the importance of understanding genetic mutations is key for accurate diagnosis and effective treatment. The use of AI is becoming more common across many medical disciplines, including genetics. AI algorithms can examine and analyze large datasets of genetic data, identify patterns, and deliver analyses at speed and precision.
As AI becomes more prominent in healthcare, it can reshape disease prevention, diagnosis, and treatment, providing new insights and leading to better health outcomes. This blog post will outline for you the AI in genomics market landscape and explore some of the key factors that are moving it forward.
AI in Genomics Analysis: Overview
AI plays a crucial role in genomics analysis and the genetic analysis market. For genomic analysis, AI algorithms, including machine learning and deep learning, analyze and translate vast datasets of genetic data. These AI algorithms detect patterns, predict outcomes, and classify genetic variation with multiple datasets. AI models can analyze genomic, gene expression, and epigenetic data to identify genetic mutations and their potential effects. It provides many benefits over conventional methods, including greater precision, more productive analysis, detection of new mutations, personalized medicine through integration with clinical data, and biomarker detection.
Key Market Stats
The AI in genomics market was valued at USD 689.47 million in 2023 and is expected to grow to USD 16,757.95 million by 2032. The market is projected to account for a CAGR of 42.60% during the forecast period, 2024 to 2032.
The rapid growth of biomedical research funding and the extensive scale of alliances has led to a significant increase in the generation of genomic data. An estimated 2 to 40 million gigabytes of genomic data are generated each year. This growth in genomic data production is a prominent driving force behind market growth. AI technologies involving machine learning (ML) and deep learning (DL) algorithms are being used to manage and inspect large datasets. These AI-powered solutions enable researchers to challenge assumptions and accelerate discoveries in genomics research.
AI in Genomics Applications
AI solutions such as DeepSEA and ExPecto are changing how the detection and interpretation of genetic mutations is done. DeepSEA is a method based on algorithms from the deep learning market, specifically designed to predict the effects of sequence alterations on chromatin. It can precisely forecast the epigenetic state of a sequence, including transcription factor binding, DNase I sensitivity, and histone marks, across numerous cell types. This potential enables DeepSEA to forecast the chromatin effects of sequence variants and categorize managerial variants.
ExPecto is another DL-based approach that also focuses on gene regulation. Using a DNA sequence, it can accurately predict the transcriptional effects of mutations that are tissue-type specific. Within the AI in genomics market, this includes the potential to predict the effects of rare or previously masked mutations. It differentiates causal variants within loci that are analogous to disease or characteristics and is based on publicly available genome-wide association studies (GWAS). Its predictive accuracy has been validated through analytical methods specifically for immune-related diseases.
In Conclusion
AI is important in the advancement of personalized medicine because it can process genomic data to determine an individual's risk for disease, assess treatment response, and optimize therapeutic potential. Within the AI in genomics market, AI algorithms integrate heterogeneous omics data types to achieve an overall understanding of complex biological processes and disease mechanisms and identify therapeutic targets and drug discovery.
